This is the concluding article of a three-part series. Part 1 was When the US risks being leapfrogged, and Part 2 was How the US R&D model was weakened. Part 2 of this series showed that with the disappearance of labs from major US corporations, venture capital and segments of the financial sector cooperating with […]
